83 related articles for article (PubMed ID: 21033563)
1. Antifungal susceptibility of yeasts isolated from secrection of inflamed mammary glands in cows.
Wawron W; Bochniarz M; Dabrowski R
Pol J Vet Sci; 2010; 13(3):487-90. PubMed ID: 21033563
[TBL] [Abstract][Full Text] [Related]
2. In vitro antimycotic sensitivity of yeasts isolated from infected bovine mammary glands.
McDonald JS; Richard JL; Anderson AJ; Fichtner RE
Am J Vet Res; 1980 Dec; 41(12):1987-90. PubMed ID: 7212432
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility of Prototheca zopfii isolated from bovine intramammary infections.
McDonald JS; Richard JL; Anderson AJ
Am J Vet Res; 1984 Jun; 45(6):1079-80. PubMed ID: 6742568
[TBL] [Abstract][Full Text] [Related]
4. [Comparative sensitivity of yeasts to antifungal agents using a standardized micromethod].
Guinet R
Pathol Biol (Paris); 1986 May; 34(5):536-9. PubMed ID: 3534739
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the results of in vitro antifungal susceptibility testing using the Fungitest kit and the disc diffusion test].
Buchta V; Navrátilová L; Förstl M; Kubanová P
Klin Mikrobiol Infekc Lek; 2004 Apr; 10(2):80-7. PubMed ID: 15146386
[TBL] [Abstract][Full Text] [Related]
6. [Yeasts in domestic animals: species identification and susceptibility to antifungals].
Hamal P; Koukalová D
Klin Mikrobiol Infekc Lek; 2010 Feb; 16(1):4-9. PubMed ID: 20401831
[TBL] [Abstract][Full Text] [Related]
7. Ciclopiroxolamine: in vitro antifungal activity against clinical yeast isolates.
Carrillo-Muñoz AJ; Brió S; Alonso R; del Valle O; Santos P; Quindós G
Int J Antimicrob Agents; 2002 Nov; 20(5):375-9. PubMed ID: 12431873
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of susceptibility to antifungal agents of fungal strains isolated from pregnant women with diabetes and healthy pregnant women].
Nowakowska D; Gaj Z; Sobala W; Wilczyński J
Ginekol Pol; 2009 Apr; 80(4):274-9. PubMed ID: 19507561
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
Kucukates E; Erturan Z; Susever S; Yegenoglu Y
APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609
[TBL] [Abstract][Full Text] [Related]
10. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Meis JF; Gould IM; Fu W; Colombo AL; Rodriguez-Noriega E;
J Clin Microbiol; 2007 Jun; 45(6):1735-45. PubMed ID: 17442797
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of antifungal agents against yeast species.
Bergan T; Vangdal M
Chemotherapy; 1983; 29(2):104-10. PubMed ID: 6301773
[TBL] [Abstract][Full Text] [Related]
12. Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
Cuenca-Estrella M; Gomez-Lopez A; Gutierrez MO; Buitrago MJ; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2008 Mar; 52(3):1062-5. PubMed ID: 18195057
[TBL] [Abstract][Full Text] [Related]
13. [Antimycotic sensitivity of yeast-like fungi isolated from HIV-infected patients].
Polishchuk OI; Pokas OV; Vialykh ZhE; Vasylenko LH; Koltukova NV
Mikrobiol Z; 2007; 69(3):37-43. PubMed ID: 17682529
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study of the fungistatic activity in vitro of omoconazole and 6 other imidazoles against yeasts].
Mosse M; Alric MP; Berceaux M; Fourcine N; Salhi A
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):684-7. PubMed ID: 3534768
[TBL] [Abstract][Full Text] [Related]
15. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts.
Mondello F; De Bernardis F; Girolamo A; Salvatore G; Cassone A
J Antimicrob Chemother; 2003 May; 51(5):1223-9. PubMed ID: 12668571
[TBL] [Abstract][Full Text] [Related]
17. [Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine].
Mary C; Goudard M; Blancard A; Quilici M; Regli P
Ann Biol Clin (Paris); 1989; 47(9):546-9. PubMed ID: 2558599
[TBL] [Abstract][Full Text] [Related]
18. Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
Linares MJ; Muñoz JF; Solís F; Rodríguez FC; Valero A; Casal M
Rev Esp Quimioter; 1998 Mar; 11(1):64-9. PubMed ID: 9795292
[TBL] [Abstract][Full Text] [Related]
19. Yeasts and algae isolated from cows with mastitis in the south-eastern part of Poland.
Krukowski H; Lisowski A; Rózański P; Skórka A
Pol J Vet Sci; 2006; 9(3):181-4. PubMed ID: 17020012
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
